Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound

被引:27
作者
Koda, M [1 ]
Matsunaga, Y [1 ]
Ueki, M [1 ]
Maeda, Y [1 ]
Mimura, K [1 ]
Okamoto, K [1 ]
Hosho, K [1 ]
Murawaki, Y [1 ]
机构
[1] Tottori Univ, Fac Med, Dept Internal Med 2, Tottori 6838504, Japan
关键词
ultrasound contrast agents; hepatocellular carcinoma; tumor vascularity; dynamic CT; color Doppler ultrasound;
D O I
10.1007/s00330-003-2172-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of this study was to evaluate the detection rate of tumor vessels and vascularity in hepatocellular carcinoma (HCC) by contrast-enhanced coded US using Levovist, and to compare with conventional color/power Doppler US (CDUS) and dynamic CT. Ninety nodules (72 hypo/isoechoic nodules, 18 hyperechoic nodules) in 61 patients were studied. We observed tumor vessels by continuous transmission at the early vascular phase (40 s following administration of Levovist) and vascularity by intermittent transmission (intervals of 2-3 s) at the late vascular phase (40 to approximately 120 s). The detection rate of tumor vessels at the early vascular phase was 97% in hypo/isoechoic nodules and 70% in hyperechoic nodules with high density in dynamic CT being higher than that by CDUS. Tumor vascularity at the late vascular phase in hypo/isoechoic and hyperechoic nodules was hyper-enhancement in 78 and 40%, iso-enhancement in 19 and 40%, and hypo-enhancement in 3 and 0%, respectively. The detection rates of tumor vessels and vascularity in hyperechoic nodules were similar to those by CDUS. The detection rates of tumor vessels and vascularity were not affected by the tumor size in HCC tumors with high density in dynamic CT. Contrast-enhanced US with Levovist was superior to CDUS and equal to dynamic CT to assess tumor vessels in hypo/isoechoic nodules. Although it was equal to CDUS for hyperechoic nodules, this modality is useful in evaluating tumor hemodynamics.
引用
收藏
页码:1100 / 1108
页数:9
相关论文
共 26 条
[1]   Do different types of liver lesions differ in their uptake of the microbubble contrast agent SHU 508A in the late liver phase? Early experience [J].
Blomley, MJK ;
Sidhu, PS ;
Cosgrove, DO ;
Albrecht, T ;
Harvey, CJ ;
Heckemann, RA ;
Butler-Barnes, J ;
Eckersley, RJ ;
Basilico, R .
RADIOLOGY, 2001, 220 (03) :661-667
[2]   Vascularity of hepatocellular carcinoma: Assessment with contrast-enhanced second-harmonic versus conventional power Doppler US [J].
Choi, BI ;
Kim, TK ;
Han, JK ;
Kim, AY ;
Seong, CK ;
Park, SJ .
RADIOLOGY, 2000, 214 (02) :381-386
[3]   Radiofrequency thermal ablation of hepatocellular carcinoma: Using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome [J].
Cioni, D ;
Lencioni, R ;
Rossi, S ;
Garbagnati, F ;
Donati, F ;
Crocetti, L ;
Bartolozzi, C .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 177 (04) :783-788
[4]   Focal hepatic masses: Enhancement patterns with SHU 508A and pulse-inversion US [J].
Dill-Macky, MJ ;
Burns, PN ;
Khalili, K ;
Wilson, SR .
RADIOLOGY, 2002, 222 (01) :95-102
[5]   Hepatocellular carcinoma: Depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display model [J].
Ding, H ;
Kudo, M ;
Onda, H ;
Suetomi, Y ;
Minami, Y ;
Maekawa, K .
RADIOLOGY, 2001, 220 (02) :349-356
[6]   Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: Comparison with dynamic CT [J].
Ding, H ;
Kudo, M ;
Onda, H ;
Suetomi, Y ;
Minami, Y ;
Chung, H ;
Kawasaki, T ;
Maekawa, K .
RADIOLOGY, 2001, 221 (03) :721-730
[7]   Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma [J].
Ding, H ;
Kudo, M ;
Onda, H ;
Suetomi, Y ;
Minami, Y ;
Maekawa, K .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 176 (03) :661-666
[8]   Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agent [J].
Ding, H ;
Kudo, M ;
Maekawa, K ;
Suetomi, Y ;
Minami, Y ;
Onda, H .
HEPATOLOGY RESEARCH, 2001, 21 (03) :242-251
[9]   Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis [J].
Fracanzani, AL ;
Burdick, L ;
Borzio, M ;
Roncalli, M ;
Bonelli, N ;
Borzio, F ;
Maraschi, A ;
Fiorelli, G ;
Fargion, S .
HEPATOLOGY, 2001, 34 (06) :1109-1112
[10]   COLOR DOPPLER SONOGRAPHY OF HEPATIC-TUMORS WITH A GALACTOSE-BASED CONTRAST AGENT - CORRELATION WITH ANGIOGRAPHIC FINDINGS [J].
FUJIMOTO, M ;
MORIYASU, F ;
NISHIKAWA, K ;
NADA, T ;
OKUMA, M .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 163 (05) :1099-1104